

The global Aseptic Compounding Service market was valued at US$ 1157 million in 2023 and is anticipated to reach US$ 1496 million by 2030, witnessing a CAGR of 3.7% during the forecast period 2024-2030.
The aseptic compounding service market is experiencing significant growth due to the increasing demand for personalized medicine and the rising prevalence of chronic diseases. Major sales regions for aseptic compounding services include North America, Europe, Asia Pacific, and the rest of the world.North America dominates the market due to the presence of a well-established healthcare infrastructure and a high adoption rate of advanced healthcare technologies. Europe is also a significant market for aseptic compounding services, driven by the increasing geriatric population and the rising prevalence of chronic diseases.Âé¶¹Ô´´ concentration in the aseptic compounding service market is relatively high, with a few key players holding a significant market share. These players have a strong presence in multiple regions and offer a wide range of services, including sterile compounding, chemotherapy compounding, and parenteral nutrition compounding.The market offers several opportunities for growth, such as the increasing demand for customized medications, the growing need for aseptic compounding services in home healthcare settings, and the rising adoption of advanced compounding technologies. Moreover, the COVID-19 pandemic has further accelerated the demand for aseptic compounding services, as hospitals and healthcare facilities strive to ensure the safety and efficacy of medications.However, the market also faces certain challenges. One of the key challenges is the stringent regulatory requirements for aseptic compounding, which can increase the cost and complexity of operations. Additionally, the shortage of skilled personnel and the lack of standardized guidelines for aseptic compounding practices pose challenges to market growth.In terms of the latest developments in the market, there has been a growing focus on automation and robotics in aseptic compounding services. This helps to improve efficiency, reduce errors, and enhance patient safety. Furthermore, advancements in technology, such as closed-system transfer devices and compounding software, are being adopted to ensure the sterility and accuracy of compounded medications.
This report aims to provide a comprehensive presentation of the global market for Aseptic Compounding Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Aseptic Compounding Service.
Report Scope
The Aseptic Compounding Service market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Aseptic Compounding Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Aseptic Compounding Service companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Âé¶¹Ô´´ Segmentation
By Company
PureIV
Bayview Health
Slade Pharmacy
Baxter Professional
Nova Laboratories
Element Materials Technology
B. Braun Medical
CPIE
Fagron
Pharmaxo
Pavilion Compounding Pharmacy
BPS
Alfred Health
Visante
ITH Pharma
NexGen Pharma
Complementary Compounding Services
Medisca
Wedgewood
Green Dispensary Compounding
Fresenius
Discover Pharmacy
Kingsway Compounding
Wesley Pharmacy
Oxford Compounding
Skycare Pharmacy
Greenpark Compounding
Potter's House Apothecary
Segment by Type
PIA
PAA
CUPM
PDA
SAPM
Segment by Application
Adult
Child
Animal
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Aseptic Compounding Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Âé¶¹Ô´´ Analysis by Type
1.2.1 Global Aseptic Compounding Service Âé¶¹Ô´´ Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 PIA
1.2.3 PAA
1.2.4 CUPM
1.2.5 PDA
1.2.6 SAPM
1.3 Âé¶¹Ô´´ by Application
1.3.1 Global Aseptic Compounding Service Âé¶¹Ô´´ Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Adult
1.3.3 Child
1.3.4 Animal
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Aseptic Compounding Service Âé¶¹Ô´´ Perspective (2019-2030)
2.2 Aseptic Compounding Service Growth Trends by Region
2.2.1 Global Aseptic Compounding Service Âé¶¹Ô´´ Size by Region: 2019 VS 2023 VS 2030
2.2.2 Aseptic Compounding Service Historic Âé¶¹Ô´´ Size by Region (2019-2024)
2.2.3 Aseptic Compounding Service Forecasted Âé¶¹Ô´´ Size by Region (2025-2030)
2.3 Aseptic Compounding Service Âé¶¹Ô´´ Dynamics
2.3.1 Aseptic Compounding Service Industry Trends
2.3.2 Aseptic Compounding Service Âé¶¹Ô´´ Drivers
2.3.3 Aseptic Compounding Service Âé¶¹Ô´´ Challenges
2.3.4 Aseptic Compounding Service Âé¶¹Ô´´ Restraints
3 Competition Landscape by Key Players
3.1 Global Top Aseptic Compounding Service Players by Revenue
3.1.1 Global Top Aseptic Compounding Service Players by Revenue (2019-2024)
3.1.2 Global Aseptic Compounding Service Revenue Âé¶¹Ô´´ Share by Players (2019-2024)
3.2 Global Aseptic Compounding Service Âé¶¹Ô´´ Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Aseptic Compounding Service Revenue
3.4 Global Aseptic Compounding Service Âé¶¹Ô´´ Concentration Ratio
3.4.1 Global Aseptic Compounding Service Âé¶¹Ô´´ Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Aseptic Compounding Service Revenue in 2023
3.5 Aseptic Compounding Service Key Players Head office and Area Served
3.6 Key Players Aseptic Compounding Service Product Solution and Service
3.7 Date of Enter into Aseptic Compounding Service Âé¶¹Ô´´
3.8 Mergers & Acquisitions, Expansion Plans
4 Aseptic Compounding Service Breakdown Data by Type
4.1 Global Aseptic Compounding Service Historic Âé¶¹Ô´´ Size by Type (2019-2024)
4.2 Global Aseptic Compounding Service Forecasted Âé¶¹Ô´´ Size by Type (2025-2030)
5 Aseptic Compounding Service Breakdown Data by Application
5.1 Global Aseptic Compounding Service Historic Âé¶¹Ô´´ Size by Application (2019-2024)
5.2 Global Aseptic Compounding Service Forecasted Âé¶¹Ô´´ Size by Application (2025-2030)
6 North America
6.1 North America Aseptic Compounding Service Âé¶¹Ô´´ Size (2019-2030)
6.2 North America Aseptic Compounding Service Âé¶¹Ô´´ Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Aseptic Compounding Service Âé¶¹Ô´´ Size by Country (2019-2024)
6.4 North America Aseptic Compounding Service Âé¶¹Ô´´ Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Aseptic Compounding Service Âé¶¹Ô´´ Size (2019-2030)
7.2 Europe Aseptic Compounding Service Âé¶¹Ô´´ Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Aseptic Compounding Service Âé¶¹Ô´´ Size by Country (2019-2024)
7.4 Europe Aseptic Compounding Service Âé¶¹Ô´´ Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Aseptic Compounding Service Âé¶¹Ô´´ Size (2019-2030)
8.2 Asia-Pacific Aseptic Compounding Service Âé¶¹Ô´´ Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Aseptic Compounding Service Âé¶¹Ô´´ Size by Region (2019-2024)
8.4 Asia-Pacific Aseptic Compounding Service Âé¶¹Ô´´ Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Aseptic Compounding Service Âé¶¹Ô´´ Size (2019-2030)
9.2 Latin America Aseptic Compounding Service Âé¶¹Ô´´ Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Aseptic Compounding Service Âé¶¹Ô´´ Size by Country (2019-2024)
9.4 Latin America Aseptic Compounding Service Âé¶¹Ô´´ Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Aseptic Compounding Service Âé¶¹Ô´´ Size (2019-2030)
10.2 Middle East & Africa Aseptic Compounding Service Âé¶¹Ô´´ Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Aseptic Compounding Service Âé¶¹Ô´´ Size by Country (2019-2024)
10.4 Middle East & Africa Aseptic Compounding Service Âé¶¹Ô´´ Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 PureIV
11.1.1 PureIV Company Detail
11.1.2 PureIV Business Overview
11.1.3 PureIV Aseptic Compounding Service Introduction
11.1.4 PureIV Revenue in Aseptic Compounding Service Business (2019-2024)
11.1.5 PureIV Recent Development
11.2 Bayview Health
11.2.1 Bayview Health Company Detail
11.2.2 Bayview Health Business Overview
11.2.3 Bayview Health Aseptic Compounding Service Introduction
11.2.4 Bayview Health Revenue in Aseptic Compounding Service Business (2019-2024)
11.2.5 Bayview Health Recent Development
11.3 Slade Pharmacy
11.3.1 Slade Pharmacy Company Detail
11.3.2 Slade Pharmacy Business Overview
11.3.3 Slade Pharmacy Aseptic Compounding Service Introduction
11.3.4 Slade Pharmacy Revenue in Aseptic Compounding Service Business (2019-2024)
11.3.5 Slade Pharmacy Recent Development
11.4 Baxter Professional
11.4.1 Baxter Professional Company Detail
11.4.2 Baxter Professional Business Overview
11.4.3 Baxter Professional Aseptic Compounding Service Introduction
11.4.4 Baxter Professional Revenue in Aseptic Compounding Service Business (2019-2024)
11.4.5 Baxter Professional Recent Development
11.5 Nova Laboratories
11.5.1 Nova Laboratories Company Detail
11.5.2 Nova Laboratories Business Overview
11.5.3 Nova Laboratories Aseptic Compounding Service Introduction
11.5.4 Nova Laboratories Revenue in Aseptic Compounding Service Business (2019-2024)
11.5.5 Nova Laboratories Recent Development
11.6 Element Materials Technology
11.6.1 Element Materials Technology Company Detail
11.6.2 Element Materials Technology Business Overview
11.6.3 Element Materials Technology Aseptic Compounding Service Introduction
11.6.4 Element Materials Technology Revenue in Aseptic Compounding Service Business (2019-2024)
11.6.5 Element Materials Technology Recent Development
11.7 B. Braun Medical
11.7.1 B. Braun Medical Company Detail
11.7.2 B. Braun Medical Business Overview
11.7.3 B. Braun Medical Aseptic Compounding Service Introduction
11.7.4 B. Braun Medical Revenue in Aseptic Compounding Service Business (2019-2024)
11.7.5 B. Braun Medical Recent Development
11.8 CPIE
11.8.1 CPIE Company Detail
11.8.2 CPIE Business Overview
11.8.3 CPIE Aseptic Compounding Service Introduction
11.8.4 CPIE Revenue in Aseptic Compounding Service Business (2019-2024)
11.8.5 CPIE Recent Development
11.9 Fagron
11.9.1 Fagron Company Detail
11.9.2 Fagron Business Overview
11.9.3 Fagron Aseptic Compounding Service Introduction
11.9.4 Fagron Revenue in Aseptic Compounding Service Business (2019-2024)
11.9.5 Fagron Recent Development
11.10 Pharmaxo
11.10.1 Pharmaxo Company Detail
11.10.2 Pharmaxo Business Overview
11.10.3 Pharmaxo Aseptic Compounding Service Introduction
11.10.4 Pharmaxo Revenue in Aseptic Compounding Service Business (2019-2024)
11.10.5 Pharmaxo Recent Development
11.11 Pavilion Compounding Pharmacy
11.11.1 Pavilion Compounding Pharmacy Company Detail
11.11.2 Pavilion Compounding Pharmacy Business Overview
11.11.3 Pavilion Compounding Pharmacy Aseptic Compounding Service Introduction
11.11.4 Pavilion Compounding Pharmacy Revenue in Aseptic Compounding Service Business (2019-2024)
11.11.5 Pavilion Compounding Pharmacy Recent Development
11.12 BPS
11.12.1 BPS Company Detail
11.12.2 BPS Business Overview
11.12.3 BPS Aseptic Compounding Service Introduction
11.12.4 BPS Revenue in Aseptic Compounding Service Business (2019-2024)
11.12.5 BPS Recent Development
11.13 Alfred Health
11.13.1 Alfred Health Company Detail
11.13.2 Alfred Health Business Overview
11.13.3 Alfred Health Aseptic Compounding Service Introduction
11.13.4 Alfred Health Revenue in Aseptic Compounding Service Business (2019-2024)
11.13.5 Alfred Health Recent Development
11.14 Visante
11.14.1 Visante Company Detail
11.14.2 Visante Business Overview
11.14.3 Visante Aseptic Compounding Service Introduction
11.14.4 Visante Revenue in Aseptic Compounding Service Business (2019-2024)
11.14.5 Visante Recent Development
11.15 ITH Pharma
11.15.1 ITH Pharma Company Detail
11.15.2 ITH Pharma Business Overview
11.15.3 ITH Pharma Aseptic Compounding Service Introduction
11.15.4 ITH Pharma Revenue in Aseptic Compounding Service Business (2019-2024)
11.15.5 ITH Pharma Recent Development
11.16 NexGen Pharma
11.16.1 NexGen Pharma Company Detail
11.16.2 NexGen Pharma Business Overview
11.16.3 NexGen Pharma Aseptic Compounding Service Introduction
11.16.4 NexGen Pharma Revenue in Aseptic Compounding Service Business (2019-2024)
11.16.5 NexGen Pharma Recent Development
11.17 Complementary Compounding Services
11.17.1 Complementary Compounding Services Company Detail
11.17.2 Complementary Compounding Services Business Overview
11.17.3 Complementary Compounding Services Aseptic Compounding Service Introduction
11.17.4 Complementary Compounding Services Revenue in Aseptic Compounding Service Business (2019-2024)
11.17.5 Complementary Compounding Services Recent Development
11.18 Medisca
11.18.1 Medisca Company Detail
11.18.2 Medisca Business Overview
11.18.3 Medisca Aseptic Compounding Service Introduction
11.18.4 Medisca Revenue in Aseptic Compounding Service Business (2019-2024)
11.18.5 Medisca Recent Development
11.19 Wedgewood
11.19.1 Wedgewood Company Detail
11.19.2 Wedgewood Business Overview
11.19.3 Wedgewood Aseptic Compounding Service Introduction
11.19.4 Wedgewood Revenue in Aseptic Compounding Service Business (2019-2024)
11.19.5 Wedgewood Recent Development
11.20 Green Dispensary Compounding
11.20.1 Green Dispensary Compounding Company Detail
11.20.2 Green Dispensary Compounding Business Overview
11.20.3 Green Dispensary Compounding Aseptic Compounding Service Introduction
11.20.4 Green Dispensary Compounding Revenue in Aseptic Compounding Service Business (2019-2024)
11.20.5 Green Dispensary Compounding Recent Development
11.21 Fresenius
11.21.1 Fresenius Company Detail
11.21.2 Fresenius Business Overview
11.21.3 Fresenius Aseptic Compounding Service Introduction
11.21.4 Fresenius Revenue in Aseptic Compounding Service Business (2019-2024)
11.21.5 Fresenius Recent Development
11.22 Discover Pharmacy
11.22.1 Discover Pharmacy Company Detail
11.22.2 Discover Pharmacy Business Overview
11.22.3 Discover Pharmacy Aseptic Compounding Service Introduction
11.22.4 Discover Pharmacy Revenue in Aseptic Compounding Service Business (2019-2024)
11.22.5 Discover Pharmacy Recent Development
11.23 Kingsway Compounding
11.23.1 Kingsway Compounding Company Detail
11.23.2 Kingsway Compounding Business Overview
11.23.3 Kingsway Compounding Aseptic Compounding Service Introduction
11.23.4 Kingsway Compounding Revenue in Aseptic Compounding Service Business (2019-2024)
11.23.5 Kingsway Compounding Recent Development
11.24 Wesley Pharmacy
11.24.1 Wesley Pharmacy Company Detail
11.24.2 Wesley Pharmacy Business Overview
11.24.3 Wesley Pharmacy Aseptic Compounding Service Introduction
11.24.4 Wesley Pharmacy Revenue in Aseptic Compounding Service Business (2019-2024)
11.24.5 Wesley Pharmacy Recent Development
11.25 Oxford Compounding
11.25.1 Oxford Compounding Company Detail
11.25.2 Oxford Compounding Business Overview
11.25.3 Oxford Compounding Aseptic Compounding Service Introduction
11.25.4 Oxford Compounding Revenue in Aseptic Compounding Service Business (2019-2024)
11.25.5 Oxford Compounding Recent Development
11.26 Skycare Pharmacy
11.26.1 Skycare Pharmacy Company Detail
11.26.2 Skycare Pharmacy Business Overview
11.26.3 Skycare Pharmacy Aseptic Compounding Service Introduction
11.26.4 Skycare Pharmacy Revenue in Aseptic Compounding Service Business (2019-2024)
11.26.5 Skycare Pharmacy Recent Development
11.27 Greenpark Compounding
11.27.1 Greenpark Compounding Company Detail
11.27.2 Greenpark Compounding Business Overview
11.27.3 Greenpark Compounding Aseptic Compounding Service Introduction
11.27.4 Greenpark Compounding Revenue in Aseptic Compounding Service Business (2019-2024)
11.27.5 Greenpark Compounding Recent Development
11.28 Potter's House Apothecary
11.28.1 Potter's House Apothecary Company Detail
11.28.2 Potter's House Apothecary Business Overview
11.28.3 Potter's House Apothecary Aseptic Compounding Service Introduction
11.28.4 Potter's House Apothecary Revenue in Aseptic Compounding Service Business (2019-2024)
11.28.5 Potter's House Apothecary Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
PureIV
Bayview Health
Slade Pharmacy
Baxter Professional
Nova Laboratories
Element Materials Technology
B. Braun Medical
CPIE
Fagron
Pharmaxo
Pavilion Compounding Pharmacy
BPS
Alfred Health
Visante
ITH Pharma
NexGen Pharma
Complementary Compounding Services
Medisca
Wedgewood
Green Dispensary Compounding
Fresenius
Discover Pharmacy
Kingsway Compounding
Wesley Pharmacy
Oxford Compounding
Skycare Pharmacy
Greenpark Compounding
Potter's House Apothecary
Ìý
Ìý
*If Applicable.